Reckitt Benckiser pulls out of Pfizer consumer health auction

Reckitt's exit from the sale process strengthens the hand of British pharmaceutical company GlaxoSmithKline Plc, which sources familiar with the matter said was working on an offer for the business. It is possible that Pfizer will receive more offers by Thursday's deadline for bids, the sources added. "An acquisition for the whole Pfizer consumer health business did not fit our acquisition criteria and an acquisition of part of the business was not possible," Reckitt said.